Proactive - Interviews for investors

Tooru PLC (AIM:TOO, FRA:73N) CEO Scott Livingston talked with Proactive's Stephen Gunnion about the deal to buy Mylky BV, a Dutch e-commerce business that sells small home appliances enabling consumers to make their own plant-based milks, and how it fits into the company's broader growth strategy. Livingston outlined how Mylky has achieved rapid success, growing to €9 million in revenue within just two years. He attributed this to the product's unique technology, strong intellectual property, and highly effective direct-to-consumer marketing approach across Europe. He said, “Mylky in a very short space of time has… grown exponentially,” highlighting the strength of the brand's execution and market fit. The acquisition, valued at £12 million, was structured to minimise risk while leveraging Mylky's profitability, cash position, and subscription-based business model. Livingston emphasised the importance of recurring revenue streams, including ingredient subscriptions and potential cross-branding opportunities with Pulsin. The deal also brings access to a customer base of over 70,000 users, which he described as a valuable asset for future growth. Looking ahead, Livingston identified the UK as a major untapped opportunity. The company plans to launch Mylky in the region through a co-branded strategy with Pulsin, supported by data-driven marketing and consumer insights gained from other European markets. For more insights, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications for future content. #TooruPLC #Mylky #Acquisition #UKMarket #FoodTech #SubscriptionBusiness #DTC #GrowthStrategy #Pulsin #InvestorNews #ConsumerBrands #BusinessGrowth #M&A

HANetf co-CEO Hector McNeil joined Proactive's Stephen Gunnion to make the case for the Drone UCITS ETF (LSE:DRON), targeting what he estimates will be $150 billion of drone spending between now and 2030. McNeil explained that modern conflicts have turned drones into a dominant force — low-cost, scalable, and increasingly decisive on the battlefield. But the opportunity extends beyond defence, with commercial applications in agriculture, logistics and beyond, continuing to expand. The ETF takes a pure-play approach, focusing on companies where drones are core to the business rather than a footnote in a large aerospace conglomerate's accounts. The index also includes mechanisms to fast-track new IPOs, keeping exposure current as the sector evolves rapidly. For more insights like this, visit Proactive's YouTube channel, give the video a like, subscribe to the channel, and enable notifications so you never miss future updates. #DroneETF #DRON #HANetf #DroneTechnology #DefenseSpending #ETFInvesting #ThematicInvesting #UAV #Aerospace #InvestmentOpportunities #EmergingTech #CapitalMarkets

Purepoint Uranium Group CEO Chris Frostad joined Steve Darling from Proactive to report strong results from the company's winter 2026 drill program at the Nova Discovery, part of the Dorado Joint Venture Project in Saskatchewan's Athabasca Basin. Purepoint, operator of the 50/50 joint venture with IsoEnergy, completed 5,210 metres of drilling across nine holes within the Nova Zone. The program successfully extended both uranium mineralization and favourable geology, further strengthening the discovery. Downhole probe readings reached a peak of 73,100 counts per second, building on previously reported assay grades of up to 8.1% U₃O₈ at the Nova Discovery. Assay results from the winter 2026 program are currently pending. Frostad noted that the drilling campaign expanded mineralization at Nova and extended the associated geological contact to approximately one kilometre in strike length. The results have also helped establish a more refined targeting framework to support continued exploration and expansion. Looking ahead, regional drilling at the Dorado Joint Venture Project is expected to resume in late June 2026. In addition, an airborne MobileMT survey is planned for the spring, with interpretation results set to guide summer drill targeting. #proactiveinvestors #purepointuraniumgroup #tsxv #ptu #otcqb #ptuuf #UraniumExploration #DoradoProject #NorthernSaskatchewan #NovaDiscovery #IsoEnergy #HighGradeUranium #MiningExploration #DrillingResults #Geophysics #ResourceExpansion #NuclearEnergy #CriticalMinerals #ExplorationUpdate #SaskatchewanMining

1911 Gold Corporation CEO Shaun Heinrichs joined Steve Darling from Proactive to provide an update on progress at the True North mine, highlighting key milestones in the company's dewatering and rehabilitation efforts. Heinrichs reported that the dewatering program has reached approximately four metres below Level 26, enabling crews to begin rehabilitation work on that level. Dewatering to the bottom of the shaft is expected to be completed before the end of May. Once rehabilitation on Level 26 is finished, the company plans to advance diamond drilling in the high-grade 710–711 zone and begin development work required to support a return to production next year. Crews have already started cleanup activities in the shaft area on Level 26, followed by repairs to essential systems, including compressed air, ventilation, and electrical infrastructure. After dewatering the remaining 50 metres below Level 26, the company will inspect and repair the loading pocket, a critical step for test mining activities scheduled later this year. In parallel, 1911 Gold has made significant progress upgrading its mill processing facility. This includes placing deposits on a new crushing circuit to support the planned restart timeline. The mill is currently expected to be operational by mid-2026, excluding the new crushing circuit, which is scheduled for completion later in the year. To support increased activity, a new camp facility has been installed, adding capacity for 36 personnel, with an additional camp expansion planned for the third quarter of 2026. The company is also continuing to secure mobile mining equipment, either through acquisitions or deposits on new units, to support upcoming test mining and a full operational restart targeted for 2027. #proactiveinvestors #1911goldcorporation #1911gold #tsxv #aumb #otcqx #aumbf #GoldExploration #TrueNorthMine #GoldMining #MineRestart #Dewatering #MiningOperations #HighGradeGold #DiamondDrilling #MineDevelopment #ProcessingPlant #MiningInfrastructure #ResourceDevelopment #ExplorationUpdate #CanadianMining #JuniorMining

Frontier IP Group PLC (LSE:FIPP, FRA:8WT) CEO Neil Crabb joined Proactive's Stephen Gunnion to discuss a landmark €211 million Italian state-backed grant awarded to portfolio company 2D Photonics - equivalent to around 22p per Frontier share on a proportional basis. The funding will finance a pilot plant capable of manufacturing graphene-based photonic chips at scale using 200mm wafers, marking the transition from research to industrial deployment. Crabb explained that graphene's advantages over silicon - wider bandwidth, lower energy use and reduced cooling needs - make it increasingly attractive as data centres and AI models drive demand for more efficient compute infrastructure. Frontier IP holds a 9.1% stake in 2D Photonics and is making broader progress across its portfolio, with developments at Alusid, Pulsiv, GraphEnergyTech, The Vaccine Group and Cambridge Raman Imaging underpinned by strong tailwinds around sustainability and European technology sovereignty. Visit Proactive's YouTube channel for more videos, like this video, subscribe to the channel and enable notifications so you don't miss future content. #FrontierIP #NeilCrabb #Graphene #Photonics #Semiconductors #DeepTech #DataCenters #AIInfrastructure #2DPhotonics #Investing #TechStocks #Innovation #EUFunding #CleanTech #ProactiveInvestors

Quantum Blockchain Technologies PLC (AIM:QBT, FRA:BYA1) CEO Francesco Gardin joined Proactive's Stephen Gunnion to discuss the company's £500,000 placing and what it unlocks strategically. Gardin explained the raise was deliberately modest to limit dilution, while ensuring the company has firepower for near-term opportunities, including Bitcoin 2026 in Las Vegas and ongoing discussions with ASIC manufacturers under NDA. A strong cash position, he said, is essential when negotiating commercial partnerships. The other focus was BlocKeeper, a new subsidiary pursuing a capital-light "virtual mining" model - buying hashing power rather than building infrastructure. An Aquis listing for BlocKeeper is already well advanced, with a team and advisory partners in place. Gardin also confirmed strong bondholder support at a recent meeting and ruled out any plans to delist. For more videos like this, visit Proactive's YouTube channel, give this video a like, subscribe, and enable notifications so you never miss an update. #QuantumBlockchainTechnologies #BitcoinMining #Blockchain #CryptoNews #ASIC #CryptoInvesting #BlockchainTechnology #Bitcoin2026 #Fintech #SmallCaps #Investing #CryptoStrategy #QBT #DigitalAssets #MiningTechnology

Botala Energy Ltd (ASX:BTE) CEO Kris Martinick joined Proactive's Stephen Gunnion to discuss a pivotal moment at the company's Serowe CBM Project in Botswana — the spudding of well 3.5B, its first true production well. Martinick explained that years of groundwork — reservoir modelling, desorption testing and a network of dewatering wells — are now complete, making 3.5B the critical step from preparation to output. He draws parallels between Botswana's geology and Queensland, Australia, where CBM has underpinned a multi-billion-dollar LNG industry. The commercial backdrop is compelling: Southern Africa faces significant gas shortages, a gas offtake agreement is already in place, and the Botswana government is supportive. Next steps are flow testing, pilot production, and replicating success across additional wells. For more videos like this, visit Proactive's YouTube channel, give this video a like, subscribe to the channel, and enable notifications so you never miss an update. #BotalaEnergy #CBM #CoalBedMethane #BotswanaEnergy #SeroweProject #NaturalGas #EnergyTransition #LNG #GasMarket #EnergyInvestment #AfricaEnergy #ResourceDevelopment

Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker joined Proactive's Stephen Gunnion to discuss a strong start to 2026, with Q1 iodine production up 44% year-on-year to 179 metric tonnes, prompting an upgrade to H1 guidance from 325-355 metric tonnes to around 385 metric tonnes. Becker credited the ramp-up of the IO#11 plant, a strong operations team and better winter conditions for the outperformance. Looking ahead, a new, larger plant under construction in the Permian Basin is expected to process around 50,000 barrels of brine per day - double existing capacity - and produce up to 220 metric tonnes of iodine annually when it comes online in Q3. On the market, iodine prices remain firm in the mid-$70 per kilogram range, underpinned by steady demand from healthcare applications and emerging opportunities in solar and refrigerant gases. Iofina has also remained largely insulated from global supply chain disruption thanks to its diversified operations. For more insights and updates, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications for future content. #Iofina #IodineMarket #MiningStocks #ChemicalIndustry #EnergyTransition #PermianBasin #StockMarketNews #SmallCapStocks #Commodities #GrowthStocks #CEOInterview #ProactiveInvestors #MarketUpdate.

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to announce that the company has signed an exclusive, royalty-bearing commercial license agreement with The Dry Hub, an Egyptian food processing company specializing in premium dried fruits, vegetables, and herbs. Charleton explained that under the agreement, The Dry Hub will acquire a 10kW REV™ machine to begin commercial production at its facility in Egypt. The license grants exclusive rights to use EnWave's patented REV™ technology for drying select fruit, vegetable, and herb products within the Egyptian market. As part of the agreement, The Dry Hub will pay royalties consistent with EnWave's existing commercial licenses. The companies will also work closely together to optimize product development and ensure successful commercialization. To maintain exclusivity, The Dry Hub is required to purchase additional REV™ equipment within 18 months of commissioning the initial 10kW unit and meet minimum royalty commitments. The initial system represents the first phase of The Dry Hub's broader expansion strategy, as the company looks to scale production capacity and serve both business-to-consumer and business-to-business markets domestically and internationally. #proactiveinvestors #enwavecorporation #tsxv #enw #REVTechnology #FoodInnovation #AgriTech #DehydrationTech #RAndD #FoodScience #SustainableFood #CleanTech #CulinaryInnovation #FoodProcessing #AgInnovation #ProductDevelopment #FoodTech #Innovation #thedryhub #egypt

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) CEO Jeremy Skillington and principal scientist Liam Tremble joined Proactive's Stephen Gunnion to discuss a pivotal moment for the company's lead asset, POLB 001. Full MHRA clearance has been secured, clearing the final regulatory hurdle before patient screening begins across six UK sites. Interim data from the trial, which targets cytokine release syndrome — a serious complication of cancer immunotherapies — is expected this summer. On the commercial side, independent US payer research confirms multi-billion-dollar peak sales potential, with insurers recognising the significant cost burden CRS places on healthcare systems. The findings are expected to strengthen Poolbeg's hand in upcoming partnership discussions. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #PoolbegPharma #POLB001 #Biotech #ClinicalTrials #CRS #PharmaNews #DrugDevelopment #HealthcareInnovation #Investing #Biopharma #MHRA #CytokineReleaseSyndrome #LifeSciences

hVIVO PLC (AIM:HVO) CEO Yamin 'Mo' Khan joined Proactive's Stephen Gunnion to discuss the company's full-year 2025 results, which showed financial resilience despite a tough macro environment. Revenue came in at just under £47 million, in line with expectations, while EBITDA of just over £1 million beat earlier guidance of a small loss, driven by strong cost discipline, cancellation fees, and a solid Q4. The company closed the year with over £14 million in cash. Strategically, hVIVO made meaningful progress on diversification. Acquisitions, including clinical trial units in Germany and UK-based CryoStore, have broadened its capabilities, and the business is now consolidating under a single brand across four integrated service lines: human challenge trials, clinical trials, laboratory services, and consulting. Khan described the platform as giving access to "many more clients." Although the human challenge trial segment faced headwinds from vaccine market volatility in 2025, proposal activity has picked up sharply in early 2026. The company is guiding for high single-digit revenue growth this year, underpinned by a growing pipeline and a new partnership with Traws Pharma. For more insights like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #hVIVO #ClinicalTrials #Biotech #Pharma #HealthcareInvesting #LifeSciences #EarningsReport #BiotechNews #ClinicalResearch #DrugDevelopment #InvestingNews #SmallCapStocks #HealthcareInnovation #PharmaIndustry #MarketUpdate

Trillion Energy International President Scott Lower joined Steve Darling from Proactive to announce a significant light oil discovery at the Çetinkaya-1 (C-1) well in southeast Türkiye, alongside a strategic realignment toward high-impact oil exploration. Lower explained that the C-1 exploration and appraisal well, located on Block M47C3,C4 in Şırnak Province, has confirmed the presence of 32.4° API light oil within the Cretaceous Beloka and Mardin Group carbonate formations. A comprehensive wireline logging program was completed, including gamma ray, resistivity, density, neutron porosity, sonic, spontaneous potential, and caliper measurements. Log analysis, conducted using Archie's equation calibrated to formation conditions, confirmed hydrocarbon-bearing intervals in both target formations. The well identified approximately 38.0 metres of net oil pay within a 76.6-metre gross reservoir interval, representing a net-to-gross ratio of about 50%. Fracture-adjusted estimates indicate gross pay of approximately 40.6 metres and net pay in the range of 36.0 to 38.5 metres. Drilling reached a depth of 2,455 metres before being halted due to loss of circulation, intersecting only about 38 metres of the targeted 250–350 metre reservoir section. As a result, more than 160 metres of prospective reservoir remains untested. To further evaluate the discovery, the company is planning a follow-up sidetrack well (C-1ST), targeting a structural crest approximately 75 to 100 metres higher, where a thicker oil column is anticipated. The discovery marks an important step in Trillion Energy's strategy to prioritize oil-focused exploration opportunities with strong potential upside. #proactiveinvestors #trillionenergyinternational #cse #tcf #otcqb #trlef #OilDiscovery #TurkeyEnergy #LightOil #OilExploration #EnergySector #Hydrocarbons #DrillingResults #Reservoir #OilAndGas #ExplorationUpdate #EnergyTransition #Upstream #ResourceDevelopment #EnergyMarkets

VivoPower's newest Advisory Council Member Khadija Mustafa joined Steve Darling from Proactive to discuss her appointment and the value she brings to the company's global AI infrastructure strategy. Mustafa brings more than two decades of international technology leadership experience, with deep expertise in artificial intelligence strategy, global partnerships, and commercialization across the United States, the Middle East, Europe, and emerging markets. She is the Founder and CEO of Beyyond.ai, a strategic advisory firm that supports nations, boards, family offices, funds, and founders in building AI ecosystems. Her work focuses on aligning innovative applications with sovereign compute capabilities, deep technology infrastructure, and real-world commercial execution. Mustafa also serves as a Lead Business Mentor and Advisor for the Harvard Alumni Entrepreneurs Accelerator. Prior to founding Beyyond.ai, Mustafa held senior executive roles at the forefront of global AI infrastructure and enterprise technology. She spent more than 20 years at Microsoft, where she led go-to-market strategies for AI and autonomous systems. During her tenure, she played a key role in a major $8.5 billion technology acquisition, managed a multi-billion-dollar hardware supply chain, and helped expand a health technology business across 79 countries in the Middle East and Africa. Her experience also includes leading international partnership strategies across Fortune 500 companies, high-growth unicorns, and emerging AI startups worldwide. VivoPower said Mustafa's appointment strengthens its ability to execute on its global AI infrastructure ambitions. Her network across hyperscalers, sovereign institutions, and frontier AI companies is expected to unlock new partnership and capital opportunities, while her track record in driving large-scale commercial outcomes positions the company to accelerate deal flow, expand into new markets, and further establish itself as a key infrastructure partner in the rapidly evolving AI sector. #proactiveinvestors #vivopowerinternationalplc #nasdaq #vvpr #AIInfrastructure #ArtificialIntelligence #TechLeadership #GlobalAI #BeyyondAI #EnterpriseTech #AICommercialization #InnovationStrategy #EmergingMarkets #Partnerships #TechAdvisory #Hyperscalers #DigitalInfrastructure #AIExpansion

Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to announce the successful deployment of the first PowerBuoy® system under its previously announced contract with the U.S. Department of Homeland Security. Stratmann explained that the system has been deployed off the coast of California to support maritime domain awareness operations for the U.S. Coast Guard, marking a key operational milestone as the company transitions its autonomous offshore infrastructure into active mission support. The PowerBuoy® platform is designed to deliver persistent offshore power, communications, and sensor integration, enabling long-endurance maritime surveillance and security operations. Operating autonomously for extended periods, the system supports continuous monitoring of maritime environments. By providing reliable offshore energy and communications capabilities, the platform enables advanced sensors and data collection technologies, enhancing situational awareness for government and defense customers. The deployment is expected to support ongoing maritime monitoring as part of broader efforts by the Department of Homeland Security to strengthen coastal and offshore security. Additional PowerBuoy systems are planned under the program, forming a networked offshore monitoring capability designed to deliver real-time maritime domain awareness. #proactiveinvestors #oceanpowertechnologiesinc #nyseamerican #optt #PhillipStratmann, #USGovernmentContract, #USCoastGuard #MaritimeSecurity #DefenseTech #AutonomousSystems #BuoySystems #WAMV #PowerBuoy #MERROWS #USCoastGuard #HomelandSecurity #AndurilIndustries #MaritimeSecurity #DefenseTech #AutonomousSystems #CleanEnergy #OceanTech #GovContracts #EnergyInnovation #TechStocks #SmallCap #EmergingTech #SecuritySolutions #BlueEconomy #Innovation

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce that the company is now cash flow positive and has completed a company-wide AI-enabled operational optimization program. The transformation is expected to deliver annualized cost savings of approximately $400,000, once remaining initiatives are fully implemented by May 1, 2026. Management noted that these efforts significantly reduce cash burn while maintaining innovation and execution speed. Gappelberg described the milestone as a key inflection point, marking Nextech3D.ai's transition to a lean, AI-first operating model designed for scalability and sustainable profitability. The company expects to officially achieve cash flow positivity as of May 1, 2026—representing the first time in its history reaching this milestone. In addition, Nextech3D.ai announced that its blockchain-based ticketing platform is now production-ready. The platform includes an integrated payment gateway and custodial wallet, enabling seamless partner integrations across its broader event technology ecosystem. Looking ahead, Nextech Event Solutions is preparing to launch a unified, end-to-end event platform. The system will integrate booth sales, interactive floor plans, registration, ticketing, badge printing, lead retrieval, and engagement tools into a single streamlined solution, positioning the company to deliver a comprehensive offering for event organizers. #proactiveinvestors #nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #KraftyLabs #AIOptimization #CashFlowPositive #TechInnovation #ArtificialIntelligence #OperationalEfficiency #ScalableGrowth #EventTech #Blockchain #DigitalTickets #Fintech #SaaS #TechTransformation #Innovation #BusinessGrowth

Kodal Minerals PLC (AIM:KOD) CEO Bernard Aylward joined Proactive's Stephen Gunnion to discuss a strong Q1 at the Bougouni Lithium Project in Mali, headlined by record monthly output of 10,900 tonnes in March. Operational improvements across mining, processing and logistics are now bearing fruit, with the company targeting shipments of 15,000 to 20,000 tonnes every six to eight weeks. Revenues since export began have exceeded $51 million, with lithium prices strengthening over that period. Looking further ahead, Kodal is advancing plans for a Phase Two flotation plant that Aylward says could support a mine life of more than 14 years — a significant milestone for a project still in its early export phase. For more insights like this, visit Proactive's YouTube channel, give this video a like, subscribe to the channel, and enable notifications so you never miss an update. #KodalMinerals #Lithium #Bougouni #MiningNews #EVs #EnergyTransition #LithiumMarket #ResourceStocks #MiningOperations #CriticalMinerals

Connecting Excellence Group PLC (AQSE:XCE, OTCQB:XCELF) CEO Scott Ellam joined Proactive's Stephen Gunnion to discuss what he claims is a UK first - a listed recruitment firm invoicing and settling fees directly in Bitcoin. Ellam explained how the transaction illustrates the company's dual flywheel model: recruitment revenues flow straight into Bitcoin treasury holdings, growing BTC per share without issuing new equity. Growth levers include headcount expansion, strong operating margins, and acquisitions of profitable recruitment businesses. Looking ahead, the company is targeting significant Bitcoin accumulation alongside organic revenue growth, with a leadership team and investor base drawn from prominent figures in both finance and the Bitcoin world. Watch the full interview to understand how Connecting Excellence Group is integrating Bitcoin into its growth strategy and what this could mean for future expansion. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #ConnectingExcellenceGroup #BitcoinTreasury #ScottEllam #CryptoStrategy #ExecutiveRecruitment #BitcoinAdoption #UKStocks #GrowthStrategy #DigitalAssets #RecruitmentIndustry #BTC #InvestorInsights #CapitalMarkets

Snail USA Chief Financial Officer Heidy Chow joined Steve Darling from Proactive to discuss the company's evolution from a successful video game publisher into a more diversified developer with a growing pipeline of original titles. Chow explained that Snail Inc., headquartered in California, has built a strong foundation through its flagship titles ARK: Survival Evolved and ARK: Survival Ascended. However, the company is now focused on expanding beyond the success of the ARK franchise and evolving into a game developer, creating a diverse portfolio that spans from indie titles to AAA games. As part of this strategy, Snail has increased investment in internal development and established its Poland-based subsidiary, Donkey Crew, to create new titles. A key milestone in this effort was the 2025 launch of Bellwright, which Chow described as a strong success. The company is now working to expand the game's reach by bringing it from PC to console platforms. Looking ahead, Snail has three new AAA titles in the final phases of development, with one AAA in-house title targeting a 2027 release. This long-term growth strategy is supported by increased investment in research and development, with profits being reinvested into future projects. Chow also highlighted improved financial efficiency, noting that the company reduced licensing costs associated with ARK: Survival Ascended, generating approximately $6 million in annual savings. These funds are being redirected into development and operations. In addition, Snail continues to grow revenue through in-game content while exploring opportunities in video initiatives and broader IP rebranding efforts. #proactiveinvestors #snail #nasdaq #snal #SnailInc #GamingIndustry #VideoGames #GameDevelopment #ARKSurvivalEvolved #ARKAscended #Bellwright #AAA Games #IndieGames #GameStudio #DigitalEntertainment #GamingNews #IPDevelopment #TechInnovation #GamePublishing

HANetf co-CEO Hector McNeil joined Proactive's Stephen Gunnion to make the case for the Ukraine Reconstruction UCITS ETF, targeting what he sees as one of the most significant investment opportunities of the decade. With reconstruction costs estimated at over $500 billion, the ETF offers diversified exposure across four pillars - industrial resilience, infrastructure, energy and defence - including a fast-track mechanism to add Ukrainian companies as domestic capital markets reopen. McNeil described Ukraine's future economy as potentially "like Israel on steroids," combining strong tech capabilities with massive international investment. He argued that waiting for peace could mean missing the move, suggesting the time to position is now before markets fully price in the recovery. Watch the full interview to understand how the Ukraine Reconstruction UCITS ETF is structured and what it could mean for investors looking at post-war recovery themes. For more insights like this, visit Proactive's YouTube channel, give the video a like, subscribe, and enable notifications so you never miss an update. #UkraineETF #HANetf #Investing #Reconstruction #UkraineRecovery #ETFInvesting #Infrastructure #EnergyInvesting #DefenseStocks #EmergingMarkets #UCITSETF #GlobalInvesting #PostWarRecovery

hVIVO PLC (AIM:HVO) chief scientific officer Dr Andrew Catchpole talked with Proactive's Stephen Gunnion about a newly signed contract with Traws to conduct an influenza human challenge trial, designed to evaluate a prophylactic antiviral drug. Dr Catchpole explained that the study will use one of hVIVO's recently developed influenza challenge models, which deliver “really robust infection rates and really good disease profiles, ideal for testing antiviral candidates.” The trial will involve 150 participants, reflecting a broader industry trend toward larger, more data-rich human challenge trials (HCTs). He highlighted that the contract demonstrates hVIVO's fully integrated service offering, with the company managing every stage of the study in-house - from protocol design and recruitment through to laboratory analysis and data management. This approach allows for greater efficiency and consistency across the trial process. Dr Catchpole also emphasised the advantages of HCTs over traditional field trials, particularly for seasonal viruses like influenza. He noted that human challenge trials remove uncertainty around virus circulation, enabling fixed timelines and budgets. As he put it: “We can assure them that we can complete the whole study within this desired time frame, because we're not at the whims of whether the virus is circulating in the community.” The discussion also explored how larger trials allow for more endpoints, multiple dosing arms, and deeper data analysis, ultimately helping to de-risk later-stage clinical development. For more insights like this, visit Proactive's YouTube channel, give the video a like, subscribe to the channel, and enable notifications for future content. #hVIVO #Influenza #ClinicalTrials #Biotech #HumanChallengeTrial #Antiviral #DrugDevelopment #PharmaNews #HealthcareInnovation #Traws

Lowland Investment Company (LON:LWI) co-fund manager James Henderson talked with Proactive's Stephen Gunnion about the trust's investment strategy, performance, and approach to balancing income with long-term capital growth. Henderson explained how the fund differentiates itself by blending large, medium, and small-cap companies to reduce volatility while capturing higher growth potential. Henderson highlighted that smaller companies have historically delivered stronger returns, noting: “Over that period the smaller companies have given the best returns, both in capital and income.” However, he emphasised that diversification across company sizes helps smooth performance and manage risk. He also outlined the trust's value-driven approach, focusing on out-of-favour companies with strong underlying businesses. He pointed to examples such as Rolls-Royce, where the fund invested before operational improvements materialised. The strategy centres on identifying companies with strong turnover potential that can improve margins over time. Discussing income, Henderson made clear that capital growth is the priority, stating that dividends are a natural outcome of growing businesses rather than the primary target. The trust currently offers a yield of around 4.2%. Henderson also addressed the trust's discount to NAV and recent performance, noting strong longer-term returns driven by takeover activity and recovery in undervalued UK stocks. Henderson expects improving sentiment toward UK equities and smaller companies to support future growth. For more insights like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #LowlandInvestmentCompany #JamesHenderson #UKEquities #ValueInvesting #IncomeInvesting #DividendGrowth #SmallCapStocks #InvestmentTrust #StockMarketUK #WealthManagement #FundManagement

First Phosphate Corp. CEO John Passalacqua joined Steve Darling from Proactive to announce that the company has received a letter of interest from Denmark's Export Credit Agency (EIFO) for up to €170 million in equipment and services financing for its igneous phosphate mine project in Saguenay–Lac-Saint-Jean, Quebec. Passalacqua explained that EIFO, which is backed by the Danish state, provides guarantees that are effectively considered AAA-rated. These guarantees support banks financing the project, with EIFO expected to participate on a pro rata and pari passu basis alongside other senior lenders. He noted that EIFO has extensive global experience in export and project finance, having supported numerous large-scale transactions across multiple industries. The proposed guarantee remains subject to EIFO's internal credit approval, completion of due diligence, and finalization of documentation. This includes standard reviews covering environmental and social considerations, as well as the establishment of borrower, guarantor, and security structures. The letter of interest is non-binding at this stage and will be governed by Danish law and jurisdiction once finalized. #proactiveinvestors #firstphosphatecorp #cse #phos #otcqx #frspf #frspf #BeginLamarche #QuebecMining #Phosphate #CriticalMinerals #EIFO #ProjectFinance #MiningFinance #QuebecMining #Saguenay #ResourceDevelopment #CleanTech #BatteryMaterials #Infrastructure #ExportFinance #MiningInvestment #EnergyTransition

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) CEO Graeme Purdy joined Proactive's Stephen Gunnion to discuss the company's collaboration with Brompton Bicycle and what it means for the commercial rollout of its Goliath solid-state battery technology. Purdy explained that while Goliath is primarily developed for electric vehicles, Ilika's 10Ah prototypes are now being applied to e-bikes — a natural fit given the technology's energy density and safety credentials. Reduced battery weight improves range and portability, making Goliath well-suited to Brompton's foldable design and multi-modal transport use case. An intrinsically safe battery also removes a key barrier for e-bikes carried on trains and buses. The 12-month programme will focus on integrating Goliath into Brompton's battery packs, with working prototype demonstrations expected ahead of on-bike trials in 2027. Purdy also flagged the broader commercial opportunity, pointing to rapidly growing global e-bike demand and stringent safety regulations in markets such as China as tailwinds for Ilika's technology. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Ilika #GoliathBatteries #EBikes #Brompton #BatteryTechnology #SolidStateBatteries #EVTechnology #CleanEnergy #EnergyStorage #MobilityInnovation #BatteryInnovation #ElectricBikes

Arecor Therapeutics PLC (AIM:AREC) CEO Sarah Howell talked with Proactive's Stephen Gunnion about the company's progress in developing next-generation treatments for diabetes and other cardio metabolic diseases, with a particular focus on its lead insulin candidate AT278 and its oral peptide delivery platform. Howell explained that Arecor is advancing AT278, an ultra-concentrated, ultra-rapid-acting insulin designed for use in automated insulin delivery (AID) systems. The company is targeting a significant unmet need among patients requiring intensive insulin therapy, particularly those who struggle with current pump limitations. She noted: “AT278 is the only insulin that meets this profile… and of course, we've shown superiority against those best-in-class insulins.” The company has made strong progress over the past year, including a co-development partnership with Sequel Med Tech to support a planned Phase 2 clinical trial in the US. Arecor also reported a positive FDA Type C meeting, giving confidence in the study design and regulatory pathway. The Phase 2 trial is expected to begin in the second half of 2026. Beyond insulin, Arecor is developing an oral peptide delivery platform, initially focused on GLP-1 therapies. Howell highlighted that the company has successfully stabilised the peptide and is now working to improve bioavailability, a key challenge in oral delivery. With a strengthened balance sheet and multiple upcoming milestones, Arecor is positioning itself to advance both its clinical and platform programmes in large, high-value markets. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #Arecor #AT278 #DiabetesTreatment #InsulinTherapy #Biotech #GLP1 #HealthcareInnovation #MedTech #ClinicalTrials #PharmaNews #DrugDevelopment #Investing #Biotechnology #AIDSystems #ObesityTreatment

Rift Helium plc (AIM:RIFT) CEO Charles FitzRoy talked with Proactive's Stephen Gunnion about the company's upcoming AIM listing, its strategic helium assets in Tanzania, and the growing importance of primary helium supply in global markets. FitzRoy outlined how Rift Helium is positioning itself as a key player in a sector where over 90% of supply is currently produced as a byproduct of natural gas. He explained: “Over 90% of the worlds helium currently is produced as a byproduct of natural gas… Rift is not associated with hydrocarbons… it is going to be primarily helium.” This distinction underpins the company's strategy to develop a scalable, standalone helium project in a proven basin, adjacent to existing discoveries in Tanzania. FitzRoy highlighted recent global supply disruptions, particularly linked to Qatar, which have removed a significant portion of helium production and reinforced the need for reliable primary sources. With a P50 resource estimate of 19BCF, Rift Helium's flagship licence represents a sizeable opportunity compared to global demand of 6.5BCF last year. The CEO also detailed the company's near-term plans following its £8 million IPO raise, including 3D seismic work and drilling two targeted wells expected in the next 12 months. He emphasised the company's cost efficiency due to relatively shallow drilling depths and its “third mover” advantage, benefiting from prior industry groundwork in Tanzania. Watch the full interview for insights into Rift Helium's strategy, market positioning, and upcoming catalysts. Visit Proactive's YouTube channel for more videos, give this video a like, subscribe to the channel, and enable notifications for future content. #RiftHelium #HeliumMarket #AIMListing #MiningStocks #EnergyTransition #TanzaniaMining #HeliumSupply #IPO2026 #NaturalResources #SmallCapStocks #Exploration #Semiconductors #InvestorNews #ProactiveInvestors #ResourceInvesting

Quantum Blockchain Technologies PLC (AIM:QBT, FRA:BYA1) CEO Francesco Gardin talked with Proactive's Stephen Gunnion about the latest developments in the company's legal recovery efforts and ongoing proceedings involving multiple defendants. Gardin opened with a positive update regarding Mediapolis, explaining that after a lengthy bankruptcy process, the company has now reached a settlement. He confirmed that QBT is set to receive 10% of the proceeds, amounting to €132,000, with payment expected within the next 60 days. The discussion then turned to the concept of court-supervised liquidation under Italian law. Gardin described this as a process similar to private bankruptcy, where a court oversees the disposal of a defendant's assets, with proceeds distributed to creditors. He clarified that this specific case relates to one of several defendants involved, stating that there are “seven individuals and two insurance companies” connected to the broader legal actions. Gardin emphasised that while one defendant has entered this process, the company continues to pursue asset recovery from others. He noted: “Given the position of exposure that the individual has with us, I mean we are in a very good position.” The CEO also confirmed that real estate assets tied to the case will be auctioned under court supervision, and that QBT is actively filing requests to seize and sell assets across multiple cases. For more updates like this, visit Proactive's YouTube channel, give the video a like, subscribe to the channel, and enable notifications so you never miss future content. #QuantumBlockchain #QBT #FrancescoGardin #BlockchainNews #LegalUpdate #AssetRecovery #CourtLiquidation #InvestingNews #ProactiveInvestors #CryptoNews #FinancialRecovery #LitigationUpdate

PT Asset Management CEO Sean Dranfield talked with Proactive's Stephen Gunnion about the current bond market environment, highlighting why he believes conditions are increasingly attractive for investors despite geopolitical uncertainty and shifting rate expectations. Dranfield explained that recent geopolitical events, including tensions involving Iran, have had a surprisingly muted impact on bond markets. He noted that both interest rates and credit spreads have seen only modest movement, reinforcing the difficulty of predicting market direction. He said this underscores the importance of focusing on fundamentals rather than forecasts. A key theme of the discussion was the opportunity at the long end of the yield curve. Dranfield pointed out that steep yield curves and higher starting yields are creating compelling return potential. He explained that even a modest decline in rates could generate strong returns, stating that investors can benefit from both income and price appreciation over time. At the same time, he highlighted opportunities in high-quality structured credit on the short end of the curve, including AAA-rated instruments. These investments, he said, can deliver “really attractive single digit total returns without reaching for either credit risk or interest rate risk,” offering stability regardless of rate movements. Dranfield emphasised a balanced approach, combining longer-duration bonds with shorter, defensive positions to manage volatility while capturing upside potential. He added that portfolios are currently positioned with a strong defensive component to help buffer against uncertainty. Watch the full interview for deeper insights into bond market strategy and positioning. For more videos like this, visit the Proactive YouTube channel, give this video a like, subscribe to the channel, and enable notifications so you never miss an update. #BondMarket #FixedIncome #InvestingStrategy #InterestRates #YieldCurve #AssetManagement #CreditMarkets #StructuredCredit #MacroOutlook #FinanceInsights #ProactiveInvestors

NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to announce that the company has filed an application for Rare Pediatric Disease Drug Designation with the U.S. FDA's Office of Orphan Products Development for NV-387 as a treatment for measles. The RPDD application is expected to be combined with the company's previously submitted Orphan Drug Designation application for NV-387, filed in February 2026, as part of a broader regulatory strategy to advance the drug candidate. If granted, the designation would make NanoViricides eligible for a Priority Review Voucher upon approval of NV-387. PRVs are tradable assets that have recently commanded values of approximately $160 million, reflecting their ability to accelerate regulatory review timelines for other drugs. Diwan emphasized the potential impact of NV-387, stating the therapy could become an important tool in addressing the resurgence of measles in the United States and globally. He added that treatment with NV-387 may support rapid recovery while helping to reduce complications, including the rare but serious post-measles “immune amnesia” effect. Currently, there are no approved antiviral treatments specifically for measles, highlighting a significant unmet medical need. The Rare Pediatric Disease Priority Review Voucher program was reauthorized in February 2026 under the Consolidated Appropriations Act, reinforcing incentives for companies developing therapies targeting serious pediatric conditions. Measles cases have been rising in the United States, with more than 1,600 laboratory-confirmed cases reported across 33 states as of early April 2026, according to the CDC. While hospitalization rates have declined compared to 2025, the disease continues to pose risks, particularly among pediatric populations, which account for approximately 70% of cases. #proactiveinvestors #nanoviricidesinc #nyseamerican #nnvc #measles #nanoviricides #NV387 #OrphanDrugDesignation #AntiviralTherapy #ClinicalTrials #PhaseII #OrphanDrugDesignation #FDA #Measles #Antiviral #HealthcareInnovation #MedicalResearch #Biopharma #PediatricHealth #GlobalHealth

U.S. Global Investors CEO Frank Holmes joined Steve Darling from Proactive to discuss the strength of global travel demand and what it means for airline investments and the Jets ETF. Holmes highlighted that despite ongoing geopolitical tensions and rising fuel costs, the airline industry continues to perform strongly, pointing to record quarterly revenue reported by Delta Air Lines as a key example. He described the sector's performance as a positive signal for the broader economy, noting, “It's like the canary in the coal mine, but in a good way… global travel demand is just strong.” Airlines have been able to pass on higher ticket prices while maintaining robust demand, supported by increased global mobility in the post-pandemic environment. The discussion also explored evolving travel patterns, including strong north-south traffic between North America and Latin America, as well as rising activity across Asia. Holmes pointed to the growing influence of digital nomads and seasonal travelers, who are helping drive bookings beyond pre-pandemic levels. He also highlighted a competitive advantage held by Delta, noting that its ownership of a refinery helps manage fuel costs and protect margins during periods of oil price volatility. Beyond airlines, Holmes emphasized continued strength in adjacent sectors such as cruise travel and cargo shipping, suggesting that the “underlying belly of the global economy remains pretty strong.” Looking ahead, he expressed optimism that geopolitical disruptions will prove temporary, while global travel demand continues its upward trajectory—supporting long-term opportunities in airline equities and ETFs such as the U.S. Global Jets ETF (JETS). #proactiveinvestors #usglobalinvestorsinc #nasdaq #TravelETFs #JETS #TRIPETF #FrankHolmes #USGlobalInvestors #AirlineStocks #CruiseStocks #SmartBeta #TravelBoom #ProactiveInvestors #USGlobalInvestors #FrankHolmes #TRIPETF #TravelStocks #CruiseStocks #AirlineETF #TravelTrends #PostCovidTravel #StockMarketInsights #ETFInvesting #CruiseBoom #AirlineDemand

TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) executive chairman Kirill Klip talked with Proactive's Stephen Gunnion about the company's latest strategic milestone following a C$4.2 million investment from Altius Minerals, a major Canadian royalty company. Klip described the investment as a strong endorsement of TNR Gold's long-term strategy, noting that Altius has taken a non-control position of 23.5 million shares. He said: “It's a strategic non-control position that signals confidence in our company,” highlighting the significance of backing from a well-established player in the mining royalty sector. The announcement triggered a strong market response, with TNR Gold's share price rising 30% following the news. Klip pointed to this as validation of the company's corporate development strategy and growing recognition of its royalty portfolio. He also outlined how the investment strengthens TNR Gold's financial position, enabling it to advance its goal of becoming a leading green energy metals royalty and gold company. The company is now focused on expanding its royalty holdings and delivering shareholder returns through potential buybacks and future dividends. Looking ahead, Klip noted that TNR Gold expects to begin receiving royalty payments in the near term, supported by production progress at its Mariana Lithium project, while continued developments at Los Azules and other assets provide additional upside. For more updates like this, visit Proactive's YouTube channel, give the video a like, subscribe, and enable notifications so you never miss new content. #TNRGold #AltiusMinerals #MiningStocks #RoyaltyCompanies #GoldStocks #Lithium #Copper #JuniorMining #InvestingNews #StockMarket #MiningInvestment #EnergyTransition #ResourceStocks

Rome Resources Plc (AIM:RMR, FRA:33R) CEO Paul Barrett talked with Proactive's Stephen Gunnion about the company's latest drilling results from the Kalayi prospect in the Democratic Republic of Congo, highlighting what he described as the strongest intercepts achieved to date. Barrett explained that the recent campaign, which covered over 3,000 metres of drilling, focused largely on Kalayi and delivered significantly wider intercepts than previously seen. He noted that “5 or 6 of the holes in this sequence have been much, much better… in terms of the widths of the intercepts,” pointing to encouraging signs for the project's scale. The company has been targeting deeper extensions of previously identified mineralisation, with early XRF readings suggesting strong continuity. While Barrett cautioned that these results remain semi-quantitative until lab assays are confirmed, he expressed confidence that the increased widths should provide a reliable indication of overall mineralisation. Importantly, new intercepts in previously untested areas could expand the footprint of the deposit. Barrett said this “could increase the footprint quite a lot,” adding that mineralisation remains open at depth, presenting further exploration upside. Looking ahead, Rome Resources is assessing next steps, including potential drilling strategies to access deeper zones more efficiently. The proximity of Kalayi to the Alphamin operation - just eight kilometres away - also provides a clear pathway toward potential development and commercialisation. For more updates like this, visit Proactive's YouTube channel, give this video a like, subscribe, and enable notifications so you never miss future content. #RomeResources #PaulBarrett #Kalayi #TinMining #DrillingResults #MiningExploration #ResourceGrowth #XRF #MiningNews #ProactiveInvestors

Fineqia International Inc (CSE:FNQ) senior associate Matteo Greco talked with Proactive's Stephen Gunnion about the latest trends shaping crypto markets in Q1 2026, highlighting how geopolitical tensions and macroeconomic uncertainty are influencing investor behaviour. Greco explained that Bitcoin continues to dominate institutional allocations, now accounting for over 81% of total crypto ETP assets under management. He noted, "BTC represents the equivalent of a safe haven in terms of crypto," as investors shift away from more volatile assets during periods of heightened uncertainty. This risk-off sentiment has been driven by geopolitical developments, including tensions involving Iran and the US, as well as concerns around inflation and potential stagflation. The discussion also explored why Ethereum has seen negative ETP flows despite price gains, with Greco attributing this to profit-taking following a strong 2025 and broader caution in the altcoin market. Meanwhile, basket ETPs have underperformed significantly, reflecting their exposure to smaller, less liquid assets that are more vulnerable during downturns. Looking ahead, Greco suggested that the next few weeks will be critical in determining the trajectory for Q2 2026, particularly as markets assess the impact of rising oil prices and evolving geopolitical risks. Despite recent market weakness, the continued growth in ETP listings signals long-term confidence in the sector. For more expert insights and market updates, visit Proactive's YouTube channel, give this video a like, subscribe to the channel, and enable notifications so you never miss future content. #Bitcoin #CryptoMarket #Ethereum #CryptoETP #Investing #DigitalAssets #BTC #CryptoNews #MarketOutlook #Blockchain #InstitutionalInvestors #RiskOff #CryptoTrends

King Ridge Capital Inc CEO Rick Pagnani talked with Proactive's Stephen Gunnion about the KRC Cat Bond UCITS ETF (CATB), explaining how catastrophe bonds work and why they can play a valuable role in diversified portfolios. Pagnani outlined that cat bonds are insurance-linked securities that allow insurers to transfer risk to capital markets. These instruments are “fully collateralised and decoupled from the insurance company,” offering investors exposure that is largely uncorrelated to traditional equity and credit markets. He highlighted that this low correlation is a key differentiator, noting that cat bonds “serve to dampen volatility and increase return.” The discussion also explored portfolio construction, with King Ridge Capital focusing on diversification across regions, perils, and issuers to build resilience against single catastrophic events. Pagnani emphasised the importance of risk management and liquidity, ensuring the portfolio can withstand shocks while maintaining steady income through coupon payments. The interview touched on real-world events, including the impact of the LA wildfires, where the broader cat bond market showed resilience, recovering quickly and delivering an annual return of over 11%. Pagnani also addressed investor allocation, suggesting cat bonds can represent around 5–10% of a portfolio, and explained why the ETF's fee structure reflects the complexity of underwriting and modelling these instruments. For investors seeking yield, diversification, and reduced correlation to traditional markets, he said CATB presents a compelling option. For more insights like this, visit Proactive's YouTube channel, give this video a like, subscribe, and enable notifications so you never miss an update. #CatBonds #ETFInvesting #FixedIncome #PortfolioDiversification #KingRidgeCapital #CATB #InsuranceLinkedSecurities #AlternativeInvestments #YieldInvesting #RiskManagement #InvestingStrategy #FinanceInsights

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to discuss the company's newly signed Research and Development License Agreement (RDLA) with Rhizome Food and Farming, a North American food company led by renowned chef Dan Barber, a recipient of multiple Michelin stars. Charleton explained that the agreement builds on prior engagement involving Row 7, which, through its connection to Barber, had entered into a rental arrangement for a small-scale 3.6kW Radiant Energy Vacuum (REV™) dehydration machine. That equipment supported the development of innovative, chef-driven food products. Row 7 is not affiliated with Rhizome, but the company has since purchased the 3.6kW REV™ system to continue advancing commercial product development. Under the RDLA, Rhizome gains broad rights to use EnWave's REV™ technology for research and development purposes. This includes collaboration with third-party food and agriculture companies on product and process innovation, as well as the production of limited volumes of commercial product for market trials. With this agreement, Rhizome joins EnWave's global network of R&D partners, which includes leading institutions such as Cornell University, the Danish Technological Institute, Queensland University of Technology (QUT) in Australia, and CNTA in Spain. These partners utilize REV™ equipment to collaborate with EnWave, applying vacuum-microwave dehydration technology to solve product-specific challenges and accelerate innovation. Rhizome plans to use REV™ technology as a core component of its culinary and agricultural research ecosystem, exploring “moonshot” ideas in shelf stability, nutrient density, and flavor. The initiative will draw on its extensive network of chefs, scientists, and industry collaborators while helping to de-risk future commercialization opportunities. #proactiveinvestors #enwavecorporation #tsxv #enw #REVTechnology #FoodInnovation #AgriTech #DehydrationTech #RAndD #FoodScience #SustainableFood #CleanTech #CulinaryInnovation #FoodProcessing #AgInnovation #ProductDevelopment #FoodTech #Innovation

Coiled Therapeutics (AIM:COIL) executive chair Dr Sotirios Stergiopoulos and CEO Sridhar Vempati talked with Proactive's Stephen Gunnion about promising clinical results for its lead oncology candidate AO-252. The discussion highlighted a significant improvement in clinical outcomes, with the company reporting an increase in clinical benefit rate from 40% to 80% following a shift to twice-daily dosing. Vempati explained that the enhanced efficacy appears linked to sustained drug exposure, noting that maintaining therapeutic levels for longer durations helps drive stronger results. He also emphasized AO-252's multimodal mechanism, targeting mitosis, DNA damage repair, and immune activation. This approach not only attacks tumors directly but may also help the immune system recognize and respond to cancer more effectively. Stergiopoulos highlighted the importance of these findings in heavily pre-treated patients, many of whom had exhausted available treatment options. He said: “The fact that we're seeing effect is really astounding… and it gives us every confidence that we are on the right path.” The ability to generate responses in such late-stage cases suggests potential for even greater efficacy in earlier treatment lines. The company is now advancing plans for combination trials and new formulations, with multiple data readouts expected throughout 2026. AO-252's favorable safety profile and synergy with existing therapies could expand its use across a wide range of cancer indications. For more insights like this, visit Proactive's YouTube channel, give this video a like, subscribe, and turn on notifications so you never miss an update. #CoiledTherapeutics #AO252 #CancerResearch #Oncology #Biotech #ClinicalTrials #DrugDevelopment #Immunotherapy #CancerTreatment #HealthcareInnovation #Biopharma #PrecisionMedicine

ICG Silver and Gold CEO Steven Sirbovan joined Steve Darling from Proactive to announce that the company has completed the staking and consolidation of eight newly available mineral claims, covering approximately 85 acres within the highly prospective Tuscarora District in Nevada. The newly acquired claims were identified through ongoing technical evaluation, incorporating recently completed geophysical surveys, historical mapping, and legacy exploration data. This work has helped outline previously underexplored structural corridors and favorable lithological contacts believed to control mineralization across the district. The company noted that securing this prospective ground—already supported by existing data—represents one of the most efficient ways to add value ahead of its planned Phase 1 drill program, scheduled to begin this summer. The expanded land package enhances ICG's exposure to a district known for favorable host lithologies, established mineral occurrences, and district-scale structural controls associated with both precious and base metal mineralization. The consolidation aligns with the company's broader strategy of building dominant land positions in high-quality exploration jurisdictions with demonstrated upside potential. ICG will refer to this newly defined area as the “Battle Mountain” target. Importantly, historical drilling on the ground provides early validation of the system. A total of 13 reverse circulation drill holes were previously completed, including six holes totaling approximately 1,280 metres with recorded assay data. #proactiveinvestors #icgsilverandgold #cse #icg #mining #TuscaroraDistrict #NevadaMining #MineralExploration #PreciousMetals #BaseMetals #MiningClaims #Phase1Drilling #BattleMountainTarget #Geophysics #ResourceDevelopment #ExplorationUpdate #StructuralControls #MiningGrowth #JuniorMining

MedPal AI CEO Jason Drummond joined Steve Darling from Proactive to talk about the rapid growth of the company's AI-powered healthcare platform and its vision to transform access to primary care. Drummond explained how MedPal AI aggregates data from connected health devices such as Apple Watch, Fitbit, and Oura Ring into a single platform, allowing users to gain real-time health insights. He highlighted the scale of this opportunity, stating, “The estimated 1.3 billion people in the world have a connected health device… the level and the quality of the information they collect in real time is incredible.” The platform combines AI-driven analysis with clinician oversight, enabling triage, diagnosis support, and prescription services. MedPal AI integrates a full end-to-end system, including robotic dispensing and rapid medication delivery, creating what Drummond describes as a “complete digital health platform” and a “health operating system.” The company has scaled strongly since launch, reaching approximately 41,000 prescription orders in a single month and achieving a run rate exceeding £5 million in revenue within just 16 weeks. Drummond emphasized the importance of combining AI with human clinicians to deliver real-world outcomes, including medication and continuous health monitoring. Looking ahead, MedPal AI is focused on expanding its footprint, with Germany recently launched and the US identified as a major future market opportunity. MedPal is a UK-based, AI-driven, closed-loop digital health platform that aggregates data from over 100 wearables/apps to provide personalized wellness insights, clinical consultations, and rapid, robotically dispensed medication delivery. It operates via a smartphone app (iOS/Android) that acts as a personal health command center, aiming to bridge the gap between wellness tracking and proactive medical care. #proactiveinvestors #medpalai #aim #mpal #MedPalAI #DigitalHealth #AIHealthcare #HealthTech #ConnectedDevices #Wearables #Telemedicine #PrescriptionDelivery #HealthPlatform #PatientCare #MedicalInnovation #AIAnalytics #HealthcareAI #GlobalHealth #HealthTechInnovation

Solvonis Therapeutics PLC (LSE:SVNS) CEO Anthony Tennyson talked with Proactive's Stephen Gunnion about the company securing two US patents that significantly strengthen its PTSD treatment program. Tennyson explained that the patents cover two distinct chemical series, reinforcing the company's intellectual property position and demonstrating that Solvonis is building “a novel chemistry platform and not just a single asset story.” He highlighted that having multiple chemically distinct approaches is critical in CNS drug discovery, increasing the likelihood of identifying compounds with the right balance of efficacy, safety, and translational potential. This strategy enhances optionality and flexibility as the program advances. The company has identified SVN-114 as its lead candidate and is now focused on progressing toward clinical development. Tennyson said Solvonis plans to pursue non-dilutive grant funding in both the UK and the US to support preclinical optimisation, with the goal of moving into IND-enabling studies and ultimately entering the clinic as efficiently as possible. Discussing the broader market, Tennyson pointed out that post-traumatic stress disorder affects around 20 million people across key markets, yet there are currently no approved treatments. He noted, “we see the granting of these patents as a validation of our science,” adding that the company aims to bring hope to patients and families impacted by PTSD. He also referenced growing interest from large pharmaceutical companies, signalling increasing commercial attention on the space. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe, and turn on notifications so you never miss an update. #Solvonis #Biotech #PTSD #DrugDevelopment #PharmaNews #ClinicalTrials #CNS #HealthcareInnovation #Biopharma #Investing #IP #Patents #SVN114 #MentalHealth #LifeSciences

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about encouraging results from the SLAB (Sarcopenia and Longevity in Aged Beagles) trial, highlighting sustained efficacy and safety following treatment. Leire explained that one of the most significant findings is the durability of the therapy's effects. Even three months after stopping treatment, the benefits observed in the dogs have been maintained. He noted: "We stopped administration three months ago... and that's exactly what we see, both in terms of safety and in terms of efficacy." This persistence is a key milestone for gene therapy, as it could shift treatment from a repeated or chronic approach to a potential one-time intervention. The durability of response also has broader implications for other indications Genflow is pursuing. Leire indicated that the results support expectations for similar long-lasting effects in future applications, including MASH. While clinical endpoints are already showing promising outcomes, the company is awaiting additional data from blood analyses and biopsies to complement these findings. These results could further validate the therapy's impact, including potential reductions in biological age. The existing data has already enabled early discussions with animal health companies regarding potential partnerships. Watch the full interview to learn more about how Genflow is advancing gene therapy innovation. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #GenflowBiosciences #GeneTherapy #SLABTrial #BiotechNews #LongevityScience #Sarcopenia #AnimalHealth #Biotechnology #ClinicalTrials #MASH #AgingResearch #HealthcareInnovation

Quantum Blockchain Technologies PLC (AIM:QBT, FRA:BYA1) CEO Francesco Gardin talked with Proactive's Stephen Gunnion about progress in the company's AI Oracle development and how it could significantly reduce deployment timelines for Bitcoin mining optimisation. Gardin explained that the company has introduced a mining development kit (MDK), allowing its AI Oracle to operate via a server connected directly to a hash board. This approach removes the need to initially adapt code for constrained mining hardware, streamlining testing and development. He said: “What is important for the potential partner is that it works on their hash board,” highlighting the importance of early-stage validation for commercial adoption. By shifting development to a server-based environment, QBT can integrate its Oracle without worrying about hardware limitations during the initial phase. Gardin noted this enables the company to “cut lead time to delivery,” with a target to complete key milestones by the end of the month. The discussion also covered compatibility with widely used mining devices such as the Antminer S9 and Bitaxe Gamma. These platforms will be used for demonstrations to third parties, supported by new communication protocols linking them to the AI Oracle running on a server. Looking ahead, QBT plans to showcase the AI Oracle at the Bitcoin 2026 conference in Las Vegas, aiming to present a live demonstration to ASIC manufacturers and industry participants. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #QuantumBlockchainTechnologies #AIOracle #BitcoinMining #CryptoInnovation #BlockchainTechnology #ASIC #Bitcoin2026 #MiningTech #CryptoDevelopment #Fintech #DigitalAssets #TechInnovation #ProactiveInvestors

Sunda Energy PLC (AIM:SNDA) CEO Andy Butler talked with Proactive's Stephen Gunnion about the company's latest strategic developments, including a transformational acquisition in New Zealand, progress across its international portfolio, and a strengthened funding position. Butler outlined how the acquisition marks a major step forward, positioning Sunda Energy as a production-focused company with significant growth potential. He said the deal “takes us to a different level,” highlighting that it introduces immediate production of over 1,000 barrels alongside opportunities to expand through development and exploration. The CEO also discussed the company's broader portfolio strategy, describing it as a “three-legged stool” comprising assets in New Zealand, Timor-Leste, and the Philippines. This structure enhances both stability and diversification, while maintaining exposure to high-impact exploration opportunities. In Timor-Leste, Sunda Energy has entered a collaboration with Finder Energy to support drilling at the Chuditch project, while in the Philippines the company continues to advance a high-impact exploration asset attracting third-party interest. Butler also detailed a structured financing package designed to support the acquisition and future growth, including institutional backing and a retail offer for existing shareholders. Looking ahead, he emphasised strong expected news flow, integration of new assets, and further drilling activity as key milestones for the year. For more insights into Sunda Energy's strategy and growth plans, visit Proactive's YouTube channel, give the video a like, subscribe to the channel, and enable notifications for future content. #SundaEnergy #AndyButler #OilAndGas #EnergyStocks #StockMarketNews #EnergySector #Investing #AIMStocks #OilProduction #EnergyUpdate #NewZealandEnergy #TimorLeste #PhilippinesEnergy #Exploration #EnergyInvestment

Quantum Helium Limited CEO Howard Mclaughlin joined Steve Darling from Proactive to announce that the company has received approval from the Bureau of Indian Affairs to assume operatorship of the Sagebrush Project in Colorado, marking a key milestone in its development strategy. McLaughlin explained that Quantum holds prospective helium resources of more than 1 billion cubic feet across its Sagebrush and Coyote Wash projects, providing a strong foundation for future growth. He noted that the operatorship approval follows an extensive and proactive engagement process with regulatory authorities and stakeholders. A recent company visit to Colorado, including meetings with the Ute Mountain Ute Tribe and relevant regulators, contributed positively to advancing and finalizing the approvals process. With operatorship now secured, Quantum is moving into the next operational phase at Sagebrush, with mobilization for an extended production test at the Sagebrush-1 well expected to begin shortly. The test, which is expected to run over several weeks, represents a key near-term milestone. Historically, the well encountered non-combustible gas with helium concentrations of approximately 2.76%, providing strong technical validation of the helium potential within the Leadville Formation. The upcoming program is designed to evaluate flow rates and confirm commercial deliverability. Importantly, results from the extended production test are expected to support the conversion of existing helium resources into reserves, a critical step toward commercial development of the project. The company has already completed extensive planning and procurement of long-lead equipment, positioning it to move efficiently into the testing phase following receipt of operatorship approval. #proactiveinvestors #QuantumHeliumLimited #aim #qhe #helium #HeliumExploration #SagebrushProject #ColoradoEnergy #HeliumResources #EnergyDevelopment #Operatorship #ResourceEstimates #ProductionTesting #OilAndGas #CleanEnergy #CriticalResources #ProjectDevelopment #EnergyMarkets #ExplorationUpdate

Bit Digital CEO Sam Tabar joined Steve Darling from Proactive to discuss the company's 2025 financial results, its strategic shift away from Bitcoin mining, and its growing focus on Ethereum staking and AI infrastructure. The company reported approximately $115 million in revenue for 2025, reflecting a deliberate transformation of its business model. Tabar explained that Bit Digital Inc has been reallocating capital away from Bitcoin mining into higher-return opportunities, particularly Ethereum staking and high-performance computing (HPC). Ethereum has emerged as a core pillar of the company's strategy, with holdings reaching approximately 155,000 ETH. The majority of these holdings are staked to generate yield, contributing to a significant increase in staking revenue. Tabar noted that “staking revenue actually increased by 300% this year,” highlighting the rapid expansion of this segment and its growing importance to overall performance. The company views Ethereum as programmable financial infrastructure, enabling both yield generation and deeper participation in network economics. Bit Digital is also expanding its exposure to AI infrastructure through its majority stake in WhiteFiber, while maintaining a disciplined approach to capital allocation. The company is actively evaluating acquisition opportunities aimed at building cash-generating businesses and establishing a long-term growth flywheel. Tabar emphasized that the company's exit from Bitcoin mining is permanent, citing declining economics and capital inefficiencies across the sector as key drivers behind the decision. #proactiveinvestors #bitdigitalinc #nasdaq #btbt #Ethereum #ETHStaking #AIInfrastructure #HighPerformanceComputing #CryptoStrategy #DigitalAssets #Blockchain #StakingRewards #TechTransformation #WhiteFiber #AIGrowth #CloudComputing #CryptoMining #FinancialResults

BlockchaAIn Digital Infrastructure, COO Eyal Rozen joined Steve Darling from Proactive to discuss the company's strategic shift toward AI-focused data centers and its recent listing on the NYSE American. Rozen explained that the company, originally founded in 2022 with a focus on Bitcoin mining, has rapidly evolved to meet surging demand for AI infrastructure. Recognizing early that AI workloads would become a dominant driver of data center demand, the company transitioned away from a pure mining model toward hosting AI colocation customers. Today, approximately 80–90% of BlockchaAIn's resources are dedicated to AI infrastructure, positioning the company to capitalize on one of the fastest-growing segments in the digital economy. Rozen emphasized the critical role of energy availability in this shift, noting that “power is king” as companies compete to secure capacity for AI operations. In response, BlockchaAIn is actively acquiring and repurposing data centers across the United States, including a recent 20-megawatt project for a major undisclosed client. This strategy includes converting legacy Bitcoin mining facilities into AI-ready infrastructure. The company is currently expanding its footprint across key U.S. regions, including the southern states and Minnesota, while simultaneously evaluating multiple acquisition opportunities. Rozen added that the U.S. remains BlockchaAIn's primary market due to its scale and strong demand dynamics. Looking ahead, the company plans to secure additional land and power resources, align customer demand with operational readiness, and raise further capital to support continued growth following its public listing. #proactiveinvestors #BlockchaAIn #nyseamerican #aib #AIInfrastructure #DataCenters #ArtificialIntelligence #DigitalInfrastructure #NYSEAmerican #AIGrowth #Colocation #BitcoinMining #EnergyDemand #CloudComputing #TechInfrastructure #DataCenterGrowth #AIRevolution #InfrastructureInvestment

Immunic Inc (NASDAQ:IMUX, FRA:10VA) chief operating officer Jason Tardio talked with Proactive's Stephen Gunnion about the importance of science-led innovation in tackling neurological diseases, particularly multiple sclerosis, on World Health Day 2026. Tardio highlighted that the biotech industry is fundamentally grounded in scientific research and data, noting that “everything we do is rooted in science.” He explained that Immunic is focused on developing innovative therapies designed to improve patient outcomes and address significant unmet medical needs. The discussion centred on multiple sclerosis (MS), a complex neurological disease that continues to present challenges despite decades of progress. Tardio pointed out that while advancements have been made, “the disease is not solved for,” with many patients still experiencing disability progression and requiring safer, more tolerable treatments. He emphasised the urgent need for innovation, particularly in progressive forms of MS where treatment options remain extremely limited. Immunic's lead asset, vidofludimus calcium, is being developed as a novel approach aimed at addressing the full spectrum of the disease. Tardio also reinforced the broader mission of the healthcare and biotech sectors, stating that the ultimate goal is to help individuals “live a better quality of life” and “a healthier life longer.” Watch the full interview to learn more about Immunic's approach to advancing MS treatment through science. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Immunic #MultipleSclerosis #BiotechInnovation #Healthcare #MSResearch #DrugDevelopment #ClinicalTrials #Neurology #WorldHealthDay #ScienceDriven #VidofludimusCalcium #PharmaNews #BiotechNews

Gelion PLC (AIM:GELN) chief technology officer Louis Adriaenssens joined Proactive's Stephen Gunnion to explain why the company's expanded collaboration with TDK Corporation could be a defining moment for its NES cathode technology. Adriaenssens revealed how Gelion has successfully transferred its technology into a pouch cell format, a critical step on the road to commercialisation, and why its cathode works seamlessly with standard lithium-ion components already used in mass manufacturing. With TDK dominant in the drone battery market and a major force in consumer electronics, this partnership is more than a vote of confidence. It's a potential launchpad into automotive, electronics and beyond — ultimately scaling to gigawatt-hour production levels. Prototype results are coming. Find out why they could be the catalyst that changes everything. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Gelion #BatteryTechnology #EnergyStorage #TDK #DroneTechnology #LithiumIon #CleanTech #BatteryInnovation #EVBatteries #TechInvesting #EnergyTransition #ProactiveInvestors

One Bullion CEO Adam Berk joined Steve Darling from Proactive to discuss the company's rapid growth following its recent public listing and its expanding gold exploration footprint across Africa. Berk explained that One Bullion Ltd has quickly established a strong presence, controlling more than 5,000 square kilometres across three key projects: Vumba, Maitengwe, and Kraaipan. He emphasized the strength of the company's operating region, describing it as one of Africa's most attractive mining jurisdictions—politically stable, transparent, and largely underexplored—offering significant upside potential for discovery. Vumba stands out as the company's flagship asset, already supported by legacy drilling and ongoing artisanal mining activity. One Bullion plans to initiate geophysical surveys within the next 60 days, followed by a targeted drill program exceeding $1 million later this year. Maitengwe is expected to follow with exploration activity in the third quarter, while Kraaipan represents a longer-term “blue sky” opportunity. The project hosts 48 identified targets, with exploration programs planned through 2027. Berk also highlighted strong corporate momentum, including the completion of a reverse takeover (RTO), a $5 million capital raise, and growing institutional participation. He added that 2026 is shaping up to be a transformative year as the company advances multiple projects in parallel. #proactiveinvestors #onebullion #GoldExploration #AfricaMining #MiningGrowth #VumbaProject #Maitengwe #Kraaipan #GoldDiscovery #MineralExploration #Geophysics #DrillingProgram #MiningInvestment #ResourceDevelopment #JuniorMining #ExplorationUpdate

Medicus Pharma Chief Medical Officer Dr Faisal Mehmud joined Steve Darling from Proactive to announce that the company has submitted an optimized Phase 2 clinical study design to the U.S. Food and Drug Administration for Teverelix. The therapy is being developed to help prevent recurrent acute urinary retention (AUR) in men with benign prostatic hyperplasia (BPH) under the company's existing open Investigational New Drug application. Mehmud explained that the updated study design has been refined under the leadership of Steven A. Kaplan, MD, FACS, a globally recognized expert in urology and men's health, who will serve as Principal Investigator. He noted that there are currently no approved pharmacological therapies specifically indicated to prevent the recurrence of AUR, which is most caused by an enlarged prostate. Medicus Pharma's proof-of-concept approach for Teverelix aims to address this unmet need, targeting a market estimated at approximately $2 billion. The revised Phase 2 study design, known as ANT-2111-02, includes a targeted sample size of approximately 126 patients across sites in the United States and Europe. The study is designed to detect a clear pharmacodynamic signal, specifically total prostate volume reduction, within an expected timeframe of about 12 weeks. The optimized design reflects a data-driven approach, reducing the study size by roughly threefold compared to the original plan. This adjustment is expected to significantly lower development costs while improving efficiency and execution speed. The streamlined approach also positions the company for earlier strategic engagement and potential partnering discussions. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #ClinicalTrials #Phase2 #Teverelix #Biotech #DrugDevelopment #FDA #Urology #BPH #AUR #MensHealth #PharmaInnovation #Healthcare #MedicalResearch #Biopharma

American Rare Earths CEO Mark Wall joined Steve Darling from Proactive to announce rapid progress on the company's pilot plant program aimed at producing pre-production rare earth concentrate from Halleck Creek ore. As part of this advancement, the company has engaged Jaye T. Pickarts, P.E. to lead the pilot plant process, bringing extensive U.S.-based rare earth and project development expertise to this critical stage. Wall explained that Pickarts is a metallurgical engineer and Registered Professional Engineer with more than four decades of experience in mine development, mineral processing, and environmental compliance. His background includes leadership roles in rare earth demonstration plants and Wyoming-based permitting and operations. In previous positions, including a senior role at engineering firm Knight Piésold, Pickarts oversaw the design, construction, and commissioning of rare earth pilot and demonstration facilities. He has also contributed to multiple technical studies, advancing projects from early scoping through to feasibility. His combined expertise in flowsheet development and plant execution will be instrumental in integrating and de-risking the Halleck Creek pilot circuit. To support the program, American Rare Earths has ordered three key pieces of front-end processing equipment. The company has already received two Induced Roll Magnetic Separators (IRMS) manufactured by Mineral Technologies, headquartered in Starke, Florida. In addition, it has ordered a “GradePro” Reflux Classifier from FLSmidth in Salt Lake City, Utah, which is currently being fabricated on an expedited schedule. The remainder of the circuit will utilize standard, well-established processing equipment, allowing the team to focus on efficiently integrating and optimizing these critical components. The company has also announced it has brought on t Tetra Tech, a U.S. based major consulting and engineering services company, to complete an Oxides to Metals study for the Company's heavy rare earths stream. The study will evaluate options to convert separated heavy rare earth oxides from the American Rare Earths Halleck Creek Project in Wyoming all the way to metal, a critical midstream step immediately preceding the manufacture of permanent magnets relied upon by defense and advanced technology sectors. #proactiveinvestors #americanrareearthslimited #asx #arr #otcqx #arrnf #adr #amrry #wyomingrareinc #RareEarths #HalleckCreek #PilotPlant #MineralProcessing #CriticalMinerals #Metallurgy #MiningInnovation #TREO #ResourceDevelopment #WyomingMining #ProcessEngineering #CleanTech #SupplyChain #ProjectDevelopment

Valereum PLC (AQSE:VLRM, FRA:6TJ, OTCQB:VLRMF) CEO Gary Cottle talked with Proactive about the launch of VGOLD, a new product aiming to differentiate itself in the growing tokenised gold market by offering yield alongside digital gold exposure. Cottle explained that VGOLD stands out as “probably the only gold token that will pay a yield or a coupon,” adding that investors who stake tokens for longer than a year could see returns between 10% and 15%. This positions VGOLD as both a store of value and an income-generating digital asset. The discussion also covered liquidity and flexibility. Cottle noted that VGOLD and its associated VGOLD-CORE tokens are designed to be “very liquid,” with the ability to convert into cash, tether gold, and other assets. This flexibility allows Valereum to actively manage and deploy capital while maintaining exposure to gold-linked instruments. Part of the strategy includes transitioning existing bond assets into VGOLD-CORE, described as a liquidity pool, subject to verification processes for underlying assets. The company expects this to enhance both returns and usability. Cottle also highlighted the importance of Valereum's collaboration with Quorium Global Photonics (QGP), describing the partnership as fundamental to building the VGOLD ecosystem. The alignment includes shared technology, revenue opportunities, and complementary asset pipelines. Looking ahead, a potential US listing remains a key objective, though dependent on achieving stable revenues. With multiple deals in progress across gold and real estate tokenisation, VGOLD is seen as a primary driver toward near-term revenue generation. For more insights like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #Valereum #VGOLD #TokenizedGold #GoldInvestment #CryptoAssets #DigitalGold #BlockchainFinance #YieldInvesting #Fintech #RealWorldAssets #RWA #CryptoNews #Investing #GoldTokens #Web3Finance

Abingdon Health PLC (AIM:ABDX) executive chairman Dr Chris Hand talked with Proactive's Stephen Gunnion about the company's strong first-half performance, recent contract wins and growth outlook in the diagnostics market. Hand explained that Abingdon Health operates as a contract development and manufacturing organisation specialising in lateral flow and rapid diagnostic testing, now offering a full-service, end-to-end solution from product development through to regulatory approval and manufacturing. This expanded “one-stop shop” model is helping differentiate the company in a competitive sector. The company reported a 45% increase in revenue in the first half, with expectations for an even stronger second half. Hand also highlighted two major contract wins, including a $2.5 million international project and a £4.8 million agreement to develop multiplex lateral flow tests. These tests allow multiple biomarkers to be analysed in a single device, moving beyond traditional yes/no diagnostics. As Hand noted, “these tests [are] basically an onsite version of a lab test,” reflecting growing demand from biotech and pharmaceutical customers. The company is also expanding its US presence, with its Madison, Wisconsin, facility supporting increased manufacturing capacity and trading of its shares on the OTCQB to improve investor access and liquidity. Looking ahead, continued contract momentum and revenue growth are expected to drive performance through the second half of the year. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #AbingdonHealth #Diagnostics #LateralFlow #Biotech #HealthcareInnovation #RapidTesting #MedTech #Pharma #InvestorNews #SmallCaps #AIMMarket #USExpansion #MultiplexTesting #GrowthStocks